Brigitte Kircher

2.0k total citations
63 papers, 1.4k citations indexed

About

Brigitte Kircher is a scholar working on Oncology, Hematology and Organic Chemistry. According to data from OpenAlex, Brigitte Kircher has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Hematology and 20 papers in Organic Chemistry. Recurrent topics in Brigitte Kircher's work include Metal complexes synthesis and properties (18 papers), Hematopoietic Stem Cell Transplantation (17 papers) and T-cell and B-cell Immunology (9 papers). Brigitte Kircher is often cited by papers focused on Metal complexes synthesis and properties (18 papers), Hematopoietic Stem Cell Transplantation (17 papers) and T-cell and B-cell Immunology (9 papers). Brigitte Kircher collaborates with scholars based in Austria, Germany and United States. Brigitte Kircher's co-authors include Ronald Gust, Ingo Ott, Petra B. Schumacher, David Nachbaur, Thomas Wiglenda, Günther Gastl, Kathrin Schmidt, Daniel Baecker, Johannes Clausen and Kerstin Bensdorf and has published in prestigious journals such as Angewandte Chemie International Edition, Circulation and Blood.

In The Last Decade

Brigitte Kircher

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Kircher Austria 22 619 592 294 245 241 63 1.4k
Sara M. Schmitt United States 14 834 1.3× 451 0.8× 1.0k 3.5× 122 0.5× 187 0.8× 20 1.9k
Michael Frezza United States 14 1.0k 1.6× 640 1.1× 847 2.9× 97 0.4× 154 0.6× 15 1.9k
Rama Krishna Narla United States 20 534 0.9× 283 0.5× 572 1.9× 155 0.6× 142 0.6× 51 1.3k
Paolo Lunghi Italy 27 1.0k 1.7× 653 1.1× 1.1k 3.6× 139 0.6× 465 1.9× 45 2.2k
Francis L. McCabe United States 18 1.0k 1.6× 623 1.1× 1.0k 3.5× 314 1.3× 66 0.3× 22 2.0k
Qihua Zhu China 24 399 0.6× 501 0.8× 665 2.3× 86 0.4× 64 0.3× 86 1.4k
Brian E. Schultz United States 18 379 0.6× 268 0.5× 881 3.0× 175 0.7× 191 0.8× 33 1.8k
Joanna Wdzieczak‐Bakala France 26 304 0.5× 840 1.4× 820 2.8× 131 0.5× 151 0.6× 60 2.1k
P Dall'Aglio Italy 15 525 0.8× 372 0.6× 239 0.8× 84 0.3× 92 0.4× 38 1.0k
Hiroshi Kosugi Japan 27 429 0.7× 799 1.3× 743 2.5× 167 0.7× 313 1.3× 112 2.3k

Countries citing papers authored by Brigitte Kircher

Since Specialization
Citations

This map shows the geographic impact of Brigitte Kircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Kircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Kircher more than expected).

Fields of papers citing papers by Brigitte Kircher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Kircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Kircher. The network helps show where Brigitte Kircher may publish in the future.

Co-authorship network of co-authors of Brigitte Kircher

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Kircher. A scholar is included among the top collaborators of Brigitte Kircher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Kircher. Brigitte Kircher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stengel, Daniel, et al.. (2025). Assessing the potential of chlorido[N,N'-bis(salicylidene)-1,2-phenylenediamine]iron(III): Exploring delivery through lipid-based nanocarriers. European Journal of Pharmaceutical Sciences. 212. 107206–107206.
2.
Huber, Klaus, Heribert Talasz, Martin Hermann, et al.. (2024). Design, synthesis, and biological evaluation of novel halogenated chlorido[N,N′-bis(salicylidene)-1,2-bis(3-methoxyphenyl)ethylenediamine]iron(III) complexes as anticancer agents. JBIC Journal of Biological Inorganic Chemistry. 29(6). 583–599. 1 indexed citations
3.
Zidorn, Christian, et al.. (2023). Cytotoxic diterpenoids from Salvia glutinosa and comparison with the tanshinone profile of danshen (Salvia miltiorrhiza). Frontiers in Plant Science. 14. 1269710–1269710. 4 indexed citations
4.
Baecker, Daniel, et al.. (2023). Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds. Archiv der Pharmazie. 356(5). e2200655–e2200655. 13 indexed citations
5.
Nam, Nguyen‐Hai, et al.. (2023). The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors. Molecules. 28(4). 1973–1973. 6 indexed citations
6.
Corinti, Davide, Giel Berden, Jos Oomens, et al.. (2023). Amino Acids as Chelating Ligands for Platinum: Enhanced Stability in an Aqueous Environment Promoted by Biocompatible Molecules. Journal of Medicinal Chemistry. 66(22). 15256–15268. 2 indexed citations
7.
Steiner, Normann, Laura Brunelli, Georg Göbel, et al.. (2021). Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience. Annals of Hematology. 100(3). 809–816. 2 indexed citations
8.
Tymoszuk, Piotr, Manfred Nairz, Natascha Brigo, et al.. (2020). Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function. Frontiers in Oncology. 10. 584477–584477. 15 indexed citations
9.
Gerner, Romana R., S Macheiner, Simon Reider, et al.. (2020). Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity. Leukemia. 34(7). 1885–1897. 18 indexed citations
11.
Kircher, Brigitte, et al.. (2018). Anti-tumour active gold(i), palladium(ii) and ruthenium(ii) complexes with thio- and selenoureato ligands: a comparative study. Dalton Transactions. 47(14). 5055–5064. 38 indexed citations
12.
Clausen, Johannes, Brigitte Kircher, Jutta Auberger, et al.. (2011). Bone marrow may be the preferable graft source in recipients homozygous for HLA-C group 2 ligands for inhibitory killer Ig-like receptors. Bone Marrow Transplantation. 47(6). 791–798. 5 indexed citations
13.
Kircher, Brigitte, Petra B. Schumacher, Andreas Petzer, et al.. (2009). Anti‐leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro. European Journal Of Haematology. 83(1). 48–56. 21 indexed citations
14.
Kircher, Brigitte, Petra B. Schumacher, & David Nachbaur. (2008). Granzymes A and B serum levels in allo-SCT. Bone Marrow Transplantation. 43(10). 787–791. 9 indexed citations
15.
Gust, Ronald, et al.. (2007). Biological effect of mono- and dinuclear alkylamine platinum(II) compounds on human lymphoma cells. Journal of Inorganic Biochemistry. 102(4). 713–720. 5 indexed citations
16.
Nachbaur, David, Petra B. Schumacher, Jutta Auberger, Johannes Clausen, & Brigitte Kircher. (2007). Vascular Endothelial Growth Factor and Activin-A Serum Levels Following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 13(8). 942–947. 19 indexed citations
18.
Ott, Ingo, Brigitte Kircher, & Ronald Gust. (2004). Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake. Journal of Inorganic Biochemistry. 98(3). 485–489. 53 indexed citations
19.
Kircher, Brigitte, et al.. (2004). No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation. Annals of Hematology. 83(9). 566–72. 3 indexed citations
20.
Kircher, Brigitte, Stefan Stevanović, Hans‐Georg Rammensee, et al.. (2004). Hematopoietic Lineage-Restricted Minor Histocompatibility Antigen HA-1 in Graft-Versus-Leukemia Activity After Donor Lymphocyte Infusion. Journal of Immunotherapy. 27(2). 156–160. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026